loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Remodulin Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 360,846Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Dr. Reddy\'s Laboratories

02 2Actavis Inc

03 4Alembic Pharmaceuticals Limited

04 4ENDO OPERATIONS

05 4Gebro Pharma

06 4Ideogen AG

07 1ORIFARM GROUP AS

08 4OrPha Swiss

09 4Sandoz B2B

10 4Teva Pharmaceutical Industries

11 33United Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : RX

Registration Country : USA

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2020-05-22

Application Number : 210214

Regulatory Info : RX

Registration Country : USA

Dr Reddy Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 1MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 5MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Treprostinil Sodium

Brand Name :

Dosage Form : Injection

Dosage Strength : 10MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Filed

Registration Country : India

Dr Reddy Company Banner

09

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

10

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

11

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : TREPROSTINIL

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2017-11-30

Application Number : 203649

Regulatory Info : RX

Registration Country : USA

blank

12

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 1MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

13

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 2.5MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

14

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 5MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

15

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 10MG/ML

Packaging :

Approval Date : 2002-05-21

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

16

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 20MG/ML

Packaging :

Approval Date : 2021-07-30

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

17

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.1MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

18

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.2MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

19

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : REMODULIN

Dosage Form : INJECTABLE;IV (INFUSION), SUBCUTANEOUS

Dosage Strength : 0.4MG/ML

Packaging :

Approval Date : 2023-09-28

Application Number : 21272

Regulatory Info : RX

Registration Country : USA

blank

20

FNCE 2024
Not Confirmed
arrow
arrow
FNCE 2024
Not Confirmed

TREPROSTINIL

Brand Name : TYVASO

Dosage Form : SOLUTION;INHALATION

Dosage Strength : 0.6MG/ML

Packaging :

Approval Date : 2009-07-30

Application Number : 22387

Regulatory Info : RX

Registration Country : USA

blank